2020/2671(RSP) Objection pursuant to Rule 112(2) and (3): Active substances, including flumioxazine
Lead committee dossier:
Progress: Awaiting plenary debate/vote
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | ARENA Maria ( S&D), METZ Tilly ( Verts/ALE), HAZEKAMP Anja ( GUE/NGL), EVI Eleonora ( NA) |
Lead committee dossier:
Legal Basis:
RoP 112-p2
Legal Basis:
RoP 112-p2Events
2020/07/10
EP - Motion for a resolution
Documents
2020/07/10
Vote in plenary scheduled
2020/06/02
EP - ARENA Maria (S&D) appointed as rapporteur in ENVI
2020/06/02
EP - METZ Tilly (Verts/ALE) appointed as rapporteur in ENVI
2020/06/02
EP - HAZEKAMP Anja (GUE/NGL) appointed as rapporteur in ENVI
2020/06/02
EP - EVI Eleonora (NA) appointed as rapporteur in ENVI
Documents
- Motion for a resolution: B9-0203/2020
- Motion for a resolution: B9-0203/2020
Activities
Votes
B9-0203/2020 - Am 1 #
2020/07/09 Outcome: +: 390, -: 259, 0: 41
B9-0203/2020 - Am 2 #
2020/07/09 Outcome: +: 385, -: 254, 0: 51
B9-0203/2020 - Am 3 #
2020/07/09 Outcome: +: 339, -: 286, 0: 64
B9-0203/2020 - Considérant T #
2020/07/09 Outcome: -: 524, +: 157, 0: 9
B9-0203/2020 - Résolution #
2020/07/10 Outcome: +: 415, -: 252, 0: 20
History
(these mark the time of scraping, not the official date of the change)
2020-07-13Show (2) Changes | Timetravel
forecasts |
|
procedure/title |
Old
Objection pursuant to Rule 112(2) and (3): Active substances, including flumioxazineNew
Resolution on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor |
2020-07-09Show (1) Changes | Timetravel
docs |
|
2020-07-07Show (2) Changes
forecasts/0 |
|
forecasts/0 |
|